Prelude Capital Management’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,812
Closed -$334K 2792
2020
Q2
$334K Buy
20,812
+2,179
+12% +$38K 0.05% 592
2020
Q1
$289K Buy
18,633
+3,630
+24% +$78K 0.06% 389
2019
Q4
$369K Buy
15,003
+14,301
+2,037% +$212K 0.05% 653
2019
Q3
$7K Sell
702
-71,998
-99% -$908K ﹤0.01% 1537
2019
Q2
$912K Buy
72,700
+71,755
+7,593% +$923K 0.09% 366
2019
Q1
$12K Sell
945
-253
-21% -$2.83K ﹤0.01% 1413
2018
Q4
$7K Buy
1,198
+642
+115% +$4.9K ﹤0.01% 1496
2018
Q3
$6K Buy
+556
New +$6.35K ﹤0.01% 1622
2017
Q2
Sell
-23,243
Closed -$399K 1989
2017
Q1
$399K Sell
23,243
-4,979
-18% -$66.3K 0.05% 368
2016
Q4
$341K Buy
+28,222
New +$295K 0.04% 401
2015
Q2
Sell
-2,400
Closed -$45K 2183
2015
Q1
$45K Sell
2,400
-5,400
-69% -$112K 0.01% 1352
2014
Q4
$147K Buy
7,800
+2,300
+42% +$53.7K 0.02% 839
2014
Q3
$149K Buy
5,500
+4,200
+323% +$131K 0.02% 845
2014
Q2
$40K Sell
1,300
-1,600
-55% -$37.7K 0.01% 1477
2014
Q1
$66K Buy
+2,900
New +$87.9K 0.01% 1188

Other funds holding EPZM